Sua seleção (0)
Detalhe da pesquisa
1.
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
N Engl J Med;
376(16): 1551-1560, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423301
2.
Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial.
J Allergy Clin Immunol;
2019 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786154
3.
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Lancet;
392(10148): 650-661, 2018 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30097359
4.
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
N Engl J Med;
375(4): 345-56, 2016 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27299809
5.
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
N Engl J Med;
375(5): 422-34, 2016 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27518661
6.
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
BMC Dermatol;
19(1): 9, 2019 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31226985
7.
Assessing the Synergistic Effect of a Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis
J Drugs Dermatol;
18(3): 279-284., 2019 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30909333
8.
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.
Lancet;
390(10091): 276-288, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596043
9.
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Lancet;
389(10086): 2287-2303, 2017 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28478972
10.
Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials.
Value Health;
21(1): 1-8, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29304933
11.
Dupilumab: A review of its use in the treatment of atopic dermatitis.
J Am Acad Dermatol;
78(3S1): S28-S36, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29471919
12.
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial.
J Am Acad Dermatol;
79(2): 277-286.e10, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29609013
13.
Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials.
J Am Acad Dermatol;
78(1): 81-89.e5, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985956
14.
Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years.
J Drugs Dermatol;
17(8): 826-832, 2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30124721
15.
Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community Practices.
J Cutan Med Surg;
22(1): 38-43, 2018 Jan/Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29056080
16.
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis.
J Cutan Med Surg;
22(1_suppl): 10S-16S, 2018 Nov/Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30439297
17.
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults.
J Cutan Med Surg;
22(1): 78-83, 2018 Jan/Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29082775
18.
OBSERVE-5: Comparison of Etanercept-Treated Psoriasis Patients From Canada and the United States.
J Cutan Med Surg;
22(3): 297-303, 2018 May/Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466863
19.
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.
J Cutan Med Surg;
: 1203475418811335, 2018 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30463418
20.
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document.
J Cutan Med Surg;
22(1_suppl): 3S-5S, 2018 Nov/Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30439298